“…Several nuclear medicine imaging tracers are available for positron emission tomography (PET)[11] and scintigraphy, including single-photon emission tomography (SPECT). The general PET-tracer 18 F-fluoro-deoxy-glucose ( 18 F-FDG) provides information on tumor metabolism [12], whereas more specialized tracers target specific pathways such as 123 I-meta-iodo-benzoguanidine ( 123 I-MIBG) [13] for scintigraphy, 18 F-dihydroxy-fluoro-L-phenylalanine ( 18 F-DOPA) [14,15,16,17,18,19], 18 F-Dopamine ( 18 F-DA) [20,21,22,23], 68 Ga-DOTA-somatostatin analogs [15,24,25,26,27] and 11 C- hydroxy ephedrine ( 11 C-HED) [28,29,30,31,32] for PET/CT. 11 C-HED is a norepinephrine analog that binds to the norepinephrine transporter and has previously shown high diagnostic sensitivity and specificity in patients with PCC/PGL [28], including post-operative surveillance following PCC/PGL resection [29] as well as for other tumors such as neuroblastoma [33,34].…”